| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Belgium |
128.28 |
25.66 |
153.94 |
4% |
5.13 |
133.41 |
26.68 |
160.09 |
16% |
20.52 |
153.93 |
30.79 |
184.72 |
|
НСР-3081/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Belgium |
192.36 |
38.47 |
230.83 |
4% |
7.69 |
200.05 |
40.01 |
240.06 |
16% |
25 |
225.05 |
45.01 |
270.06 |
|
НСР-3082/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
266.68 |
53.34 |
320.02 |
4% |
10 |
276.68 |
55.34 |
332.02 |
16% |
25 |
301.68 |
60.34 |
362.02 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
133.33 |
26.67 |
160 |
4% |
5.33 |
138.66 |
27.73 |
166.39 |
16% |
21.33 |
159.99 |
32 |
191.99 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
200 |
40 |
240 |
4% |
8 |
208 |
41.6 |
249.6 |
16% |
25 |
233 |
46.6 |
279.6 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
290.5 |
58.1 |
348.6 |
4% |
10 |
300.5 |
60.1 |
360.6 |
16% |
25 |
325.5 |
65.1 |
390.6 |
|
КЦ-2060/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
220.17 |
44.03 |
264.2 |
4% |
8.81 |
228.98 |
45.8 |
274.78 |
16% |
25 |
253.98 |
50.8 |
304.78 |
|
КЦ-2059/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
146.75 |
29.35 |
176.1 |
4% |
5.87 |
152.62 |
30.52 |
183.14 |
16% |
23.48 |
176.1 |
35.22 |
211.32 |
|
КЦ-2062/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
14.73 |
2.95 |
17.68 |
6% |
0.88 |
15.61 |
3.12 |
18.73 |
18% |
2.65 |
18.26 |
3.65 |
21.91 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015.; НСР-10687/21.10.2016; НСР-17736/17.01.2019 |
01.02.2019 |
02.02.2019 |
Активен |
3396 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
15.16 |
3.03 |
18.19 |
6% |
0.91 |
16.07 |
3.21 |
19.28 |
18% |
2.73 |
18.8 |
3.76 |
22.56 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015.; НСР-10687/21.10.2016 |
08.11.2016 |
02.12.2016 |
Неактивен |
3396 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
15.2 |
3.04 |
18.24 |
6% |
0.91 |
16.11 |
3.22 |
19.33 |
18% |
2.74 |
18.85 |
3.77 |
22.62 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015. |
21.08.2015 |
21.08.2015 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
15.82 |
3.16 |
18.98 |
6% |
0.95 |
16.77 |
3.35 |
20.12 |
18% |
2.85 |
19.62 |
3.92 |
23.54 |
|
НСР-5136/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
16.02 |
3.2 |
19.22 |
6% |
0.96 |
16.98 |
3.4 |
20.38 |
18% |
2.88 |
19.86 |
3.97 |
23.83 |
|
НСР-3080/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
16.66 |
3.33 |
19.99 |
6% |
1 |
17.66 |
3.53 |
21.19 |
18% |
3 |
20.66 |
4.13 |
24.79 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
19.03 |
3.81 |
22.84 |
6% |
1.14 |
20.17 |
4.03 |
24.2 |
18% |
3.43 |
23.6 |
4.72 |
28.32 |
|
КЦ-2056/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3396 |
| Vinblastine |
II-9569/18.08.2004 |
Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV, The Netherlands |
7.22 |
1.44 |
8.66 |
7% |
0.51 |
7.73 |
1.55 |
9.28 |
20% |
1.44 |
9.17 |
1.83 |
11 |
цената се заличава HCР-149/12.06.2013 |
КЦРР-2508/06.03.2013 |
21.03.2013 |
21.03.2013 |
Заличен |
1702 |
| Vinblastine |
II-9569/18.08.2004 |
Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV, The Netherlands; |
13.81 |
2.76 |
16.57 |
6% |
0.83 |
14.64 |
2.93 |
17.57 |
18% |
2.49 |
17.13 |
3.43 |
20.56 |
|
КЦ-833/23.04.2009 |
02.06.2009 |
02.06.2009 |
Неактивен |
1702 |
| Vinorelbine |
20060823/26.02.2012 |
Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Актавис EАД, България |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия |
49.99 |
10 |
59.99 |
4% |
2 |
51.99 |
10.4 |
62.39 |
16% |
8 |
59.99 |
12 |
71.99 |
|
HCР-468/09.07.2013 |
25.07.2013 |
25.07.2013 |
Активен |
1973 |
| Vinorelbine |
II-15561/29.12.2006 |
Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Актавис EАД, България |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия |
110 |
22 |
132 |
4% |
4.4 |
114.4 |
22.88 |
137.28 |
16% |
17.6 |
132 |
26.4 |
158.4 |
промяна на обстоятелства решение КЦРР-2853/20.03.2013 |
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
1973 |
| Vinorelbine |
20060702 |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, -, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.78 |
10.96 |
65.74 |
4% |
2.19 |
56.97 |
11.39 |
68.36 |
16% |
8.76 |
65.73 |
13.15 |
78.88 |
промяна в обстоятелства НСР-10530/06.10.2016 |
HCР-5552/29.01.2015; НСР-13110/06.07.2017 |
21.07.2017 |
02.08.2017 |
Активен |
3561 |
| Vinorelbine |
20060702 |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.86 |
10.97 |
65.83 |
4% |
2.19 |
57.05 |
11.41 |
68.46 |
16% |
8.78 |
65.83 |
13.17 |
79 |
промяна в обстоятелства НСР-10530/06.10.2016 |
HCР-5552/29.01.2015 |
12.02.2015 |
02.11.2016 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.86 |
10.97 |
65.83 |
4% |
2.19 |
57.05 |
11.41 |
68.46 |
16% |
8.78 |
65.83 |
13.17 |
79 |
|
HCР-5552/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
12.32 |
2.46 |
14.78 |
6% |
0.74 |
13.06 |
2.61 |
15.67 |
18% |
2.22 |
15.28 |
3.06 |
18.34 |
Цената е вписана в регистъра на пределните цени с решение НСР-2578/24.01.2014 |
HCР-2130/14.12.2013 |
30.12.2013 |
30.12.2013 |
Заличен |
2359 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
61.61 |
12.32 |
73.93 |
4% |
2.46 |
64.07 |
12.81 |
76.88 |
16% |
9.86 |
73.93 |
14.79 |
88.72 |
|
HCР-2130/14.12.2013 |
30.12.2013 |
30.12.2013 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
17.88 |
3.58 |
21.46 |
6% |
1.07 |
18.95 |
3.79 |
22.74 |
18% |
3.22 |
22.17 |
4.43 |
26.6 |
|
КЦРР-2510/06.03.2013 |
20.03.2013 |
20.03.2013 |
Неактивен |
2359 |